Preparation and characterization of an oily suspension for administration of omeprazole in children

Authors

  • C Cano Corral Servicio de Farmacia, Hospital SAS Jerez de la Frontera, Jerez de la Frontera, Cádiz (España)
  • ML González Rodríguez Departmento de Farmacia y Tecnología Farmacéutica, Universidad de Sevilla, (España)
  • JI Pérez Martínez Departmento de Farmacia y Tecnología Farmacéutica, Universidad de Sevilla, (España)
  • C Alarcón-Payer Servicio de Farmacia, Hospital Universitario Virgen de las Nieves, Granada (España)
  • I Martínez López Servicio de Farmacia, Hospital SAS Jerez de la Frontera, Jerez de la Frontera, Cádiz (España)
  • A Rabasco Álvarez Departmento de Farmacia y Tecnología Farmacéutica, Universidad de Sevilla, (España)

Keywords:

Omeprazole, Oily Suspension, Pediatric formula

Abstract

Aim: Develop an oral omeprazole suspension for use in the pediatric population.

Methods: For the development of the formulation was used active ingredient in powder instead of pellets, which is usually used. By instability of the drug in acid medium, we developed a preparation of an oily character. Studies were conducted to characterize the oil vehicle, organoleptic characteristics, sedimentation volume and used the technique of differential scanning calorimetry (DSC) for studies of viscosity and drug-excipient compatibility.

Results: The percentages in which the emulsified non formula were 1,54% and 4,1% surfactant agent. In the thermogram was observed that the peak melting temperature and enthalpy values of omeprazole were diminished by the presence of aspartame and also a change in the melting peak equal to 10ºC, indicating a possible interaction between omeprazole and aspartame.

Conclusions: As far as the study did managed to stabilize all components of the formula, except the sweetener should be replaced by another similar power to reach the desired formula.

Downloads

Download data is not yet available.

References

Romano C, Chiaro A, Comito D, Loddo I, Ferrau V. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy. Curr Clin Pharmacol. 2011; 6(1): 41-7.

Cury EK, Schraibman V, Faintuch S. Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children—discussion on daily practice. J Pediatr Surg. 2004; 39 (2): e4-7.

Koo S. Sedimentation velocity of bidisperse suspensions. The Journal of Industrial and Engineering Chemistry [online]. 2008 Oct [10 Ene 2012]; 14(5): [679-86] Available in: http://www.sciencedirect.com/science/article/pii/S1226086X08001238

Arias JL, López-Viota M, Clares B, Ruiz MA. Stability of fenbendazole suspensions for veterinary use: Correlation between zeta potential and sedimentation. Eur J Pharm Sci. 2008; 34 (4-5): 257-62.

Vesaratchanon JS, Nikolov A, Darsh T, Wasan C. Sedimentation of concentrated monodisperse colloidal suspensions: Role of collective particle interaction forces. Journal of Colloid and Interface Science. 2008; 322 (1): 180-9.

Vanderhoff JW, El-Aasser MS, Ugelstad J, inventors; Polymer Emulsification Process. United States patent US 4177177. 1979 Dec 4.

Llacer JM, Ruiz MA, Parera A, Gallardo V. Adsoption-desorption of ondansetron of latex particles. Drug Dev Ind Pharm. 2000; 26: 237-42.

Agatonovic-Kustrin S, Glass BD, Mangan M, Smithson J. Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation. Int j pharm. 2008; 361 (1-2): 245-50.

Agatonovic-Kustrin S, Markovic N, Ginic-Markovic M, Mangan M, Glass BD. Compatibility studies between mannitol and omeprazole sodium isomers. J pharm biomed anal. 2008; 48 (2):356-60.

Markovic N, Agotonovic-Kustrin S, Glass B, Prestidge CA. Physical and thermal characterisation of chiral omeprazole sodium salts. J pharm biomed anal. 2006; 42 (1):25-31.

Agatonovic-Kustrin S, Markovic N, Ginic-Markovic M, Mangan M, Glass BD Compatibility studies between mannitol and omeprazole sodium isomers. J pharm biomed anal. 2008; 48 (2): 356-60.

Markovic N, Agotonovic-Kustrin S, Glass B, Prestidge CA Physical and thermal characterisation of chiral omeprazole sodium salts. J pharm biomed anal. 2006; 42 (1): 25-31.

Tomassetti M, Catalani A , Rossi V , Vecchio S. Thermal analysis study of the interactions between acetaminophen and excipients in solid dosage forms and in some binary mixtures. J pharm biomed anal. 2005; 37 (5): 949-55.

Desai D , Kothari S , Huang M. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules. Int j pharm. 2008; 354 (1-2): 77-81.

Lira AM, Araújo AAS, Basílio IDJ, Santos BLL, Santana DP, Macedo RO. Compatibility studies of lapachol with pharmaceutical excipients for the development of topical formulations. Thermochim Acta. 2007; 457 (1-2): 1-6.

Published

2012-06-20

How to Cite

1.
Cano Corral C, González Rodríguez M, Pérez Martínez J, Alarcón-Payer C, Martínez López I, Rabasco Álvarez A. Preparation and characterization of an oily suspension for administration of omeprazole in children. Ars Pharm [Internet]. 2012 Jun. 20 [cited 2024 Jul. 17];53(2):29-35. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/4668

Issue

Section

Original Articles